Bavarian Nordic A/S (BVNRY)
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under th...
- Open
- 9.640
- High
- 9.640
- Low
- 9.640
- Prev. Close
- 9.640
- Volume
- 11
- Turnover
- 106.93
- Avg Price
- 9.721
- Bid/Ask Ratio
- --
- Amplitude
- 0.00%
- 52wk High
- 13.000
- Volume Ratio
- 0.01
- Turnover Ratio
- 0.00%
News
- PUBT · Aug 7 at 01:00 AM
Bavarian Nordic says Phase 2 trial supports EU approval of IMVANEX mpox vaccine in children 2-11
- PUBT · Jul 13 at 08:26 AM
Bavarian Nordic partner files chikungunya vaccine for Brazil Anvisa approval
- rttnews · Jul 2 at 09:15 AM
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal
- Unusual Whales · Jun 15 at 01:49 AM
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
- rttnews · Jun 9 at 06:19 AM
Bavarian Nordic Wins DKK 700 Million Smallpox/Mpox Vaccine Supply Contract
- Simplywall · May 15 at 01:18 AM
Bavarian Nordic (CPSE:BAVA) Q1 Margin Squeeze Challenges Bullish Profitability Narrative
